Kohei shitara (@KoheiShitara) / X

Ravi Jaiswal, MD (@RaviJaiswal___) / X

Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology

Raghav Sundar (@sundar__raghav) / X

Daniel Catenacci (@DocCatenacci) / X

Kohei shitara on X: Suggesting synergy between anti-HER2 and PD1!! Higher N of pts on treatment (40.6% vs 28.5%) in 264 pts in efficacy population and 433 safety population (58.5 vs 48.1%)

ASCO #GI22: Gastric and esophageal cancers, HER2-targeted therapy, immunotherapy, ADCs

Kohei Shitara - Staff Doctor, Chiba, Japan

Raghav Sundar (@sundar__raghav) / X

WCGIC 2023